Literature DB >> 11938351

Distinct and opposite diversifying activities of terminal transferase splice variants.

To-Ha Thai1, Mary M Purugganan, David B Roth, John F Kearney.   

Abstract

The short splice variant of mouse terminal deoxynucleotidyl transferase (TdTS) catalyzes the addition of nontemplated nucleotides (N addition) at the coding joins of B cell and T cell antigen receptor genes. However, the activity and function of the long isoform of TdT (TdTL) have not been determined. We show here, in vitro and in vivo, that TdTL is a 3'-->5' exonuclease that catalyzes the deletion of nucleotides at coding joins. These findings suggest that the two TdT isoforms may act in concert to preserve the integrity of the variable region of antigen receptors while generating diversity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11938351     DOI: 10.1038/ni788

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  15 in total

1.  No evidence for the use of DIR, D-D fusions, chromosome 15 open reading frames or VH replacement in the peripheral repertoire was found on application of an improved algorithm, JointML, to 6329 human immunoglobulin H rearrangements.

Authors:  Line Ohm-Laursen; Morten Nielsen; Stine R Larsen; Torben Barington
Journal:  Immunology       Date:  2006-10       Impact factor: 7.397

2.  Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus.

Authors:  Christy A Thomson; Steve Bryson; Gary R McLean; A Louise Creagh; Emil F Pai; John W Schrader
Journal:  EMBO J       Date:  2008-09-04       Impact factor: 11.598

3.  Functional analyses of polymorphic variants of human terminal deoxynucleotidyl transferase.

Authors:  A Troshchynsky; I Dzneladze; L Chen; Y Sheng; V Saridakis; G E Wu
Journal:  Genes Immun       Date:  2015-06-04       Impact factor: 2.676

4.  Nucleotide Composition of Human Ig Nontemplated Regions Depends on Trimming of the Flanking Gene Segments, and Terminal Deoxynucleotidyl Transferase Favors Adding Cytosine, Not Guanosine, in Most VDJ Rearrangements.

Authors:  Tina Funck; Mike Bogetofte Barnkob; Nanna Holm; Line Ohm-Laursen; Camilla Slot Mehlum; Sören Möller; Torben Barington
Journal:  J Immunol       Date:  2018-08-10       Impact factor: 5.422

5.  Human B-1 and B-2 B Cells Develop from Lin-CD34+CD38lo Stem Cells.

Authors:  Tâm D Quách; Thomas J Hopkins; Nichol E Holodick; Raja Vuyyuru; Tim Manser; Ruthee-Lu Bayer; Thomas L Rothstein
Journal:  J Immunol       Date:  2016-10-07       Impact factor: 5.422

6.  Terminal deoxynucleotidyl transferase is required for an optimal response to the polysaccharide α-1,3 dextran.

Authors:  Tamer I Mahmoud; John F Kearney
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

7.  Gene-targeted mice lacking the Trex1 (DNase III) 3'-->5' DNA exonuclease develop inflammatory myocarditis.

Authors:  Masashi Morita; Gordon Stamp; Peter Robins; Anna Dulic; Ian Rosewell; Geza Hrivnak; Graham Daly; Tomas Lindahl; Deborah E Barnes
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

8.  Early expression of two TdT isoforms in the hematopoietic system of the Mexican axolotl. Implications for the evolutionary origin of the N-nucleotide addition.

Authors:  Rachel Golub; Sébastien André; Alexandre Hassanin; Pierre Affaticati; Mani Larijani; Julien S Fellah
Journal:  Immunogenetics       Date:  2004-05-14       Impact factor: 2.846

9.  Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood.

Authors:  Tâm D Quách; Nely Rodríguez-Zhurbenko; Thomas J Hopkins; Xiaoti Guo; Ana María Hernández; Wentian Li; Thomas L Rothstein
Journal:  J Immunol       Date:  2016-01-06       Impact factor: 5.422

10.  Terminal deoxynucleotidyl transferases from elasmobranchs reveal structural conservation within vertebrates.

Authors:  Simona Bartl; Ann L Miracle; Lynn L Rumfelt; Thomas B Kepler; Evonne Mochon; Gary W Litman; Martin F Flajnik
Journal:  Immunogenetics       Date:  2003-10-25       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.